Healthcare provider profile · identity verified

Taylor Harding, APRN

Nurse Practitioner · OMAHA, NE · NPI 1639884828

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	468	78
Furosemide	Furosemide	439	96
Quetiapine Fumarate	Quetiapine Fumarate	410	68
Sertraline Hcl	Sertraline Hcl	376	75
Potassium Chloride	Potassium Chloride	374	87
Levothyroxine Sodium	Levothyroxine Sodium	332	67
Trazodone Hcl	Trazodone Hcl	310	56
Gabapentin	Gabapentin	305	54
Amlodipine Besylate	Amlodipine Besylate	281	47
Omeprazole	Omeprazole	265	42
Lisinopril	Lisinopril	249	46
Pantoprazole Sodium	Pantoprazole Sodium	233	47
Lorazepam	Lorazepam	232	79
Tramadol Hcl	Tramadol Hcl	209	68
Tamsulosin Hcl	Tamsulosin Hcl	197	30
Donepezil Hcl	Donepezil Hcl	194	38
Mirtazapine	Mirtazapine	194	31
Losartan Potassium	Losartan Potassium	181	28
Eliquis	Apixaban	170	29
Metoprolol Succinate	Metoprolol Succinate	157	34
Clopidogrel	Clopidogrel Bisulfate	147	23
Metoprolol Tartrate	Metoprolol Tartrate	144	26
Escitalopram Oxalate	Escitalopram Oxalate	136	26
Memantine Hcl	Memantine Hcl	128	23
Spironolactone	Spironolactone	122	12
Metformin Hcl	Metformin Hcl	120	23
Duloxetine Hcl	Duloxetine Hcl	113	18
Rosuvastatin Calcium	Rosuvastatin Calcium	105	11
Allopurinol	Allopurinol	103	suppressed
Simvastatin	Simvastatin	99	18
Warfarin Sodium	Warfarin Sodium	98	17
Latanoprost	Latanoprost	92	19
Fluticasone Propionate	Fluticasone Propionate	87	44
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	87	66
Hydrochlorothiazide	Hydrochlorothiazide	84	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	83	54
Atenolol	Atenolol	80	suppressed
Nyamyc	Nystatin	77	27
Famotidine	Famotidine	76	14
Buspirone Hcl	Buspirone Hcl	75	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	75	31
Myrbetriq	Mirabegron	72	12
Pregabalin	Pregabalin	71	14
Alprazolam	Alprazolam	68	21
Loperamide	Loperamide Hcl	64	44
Venlafaxine Hcl Er	Venlafaxine Hcl	64	suppressed
Oxcarbazepine	Oxcarbazepine	58	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	58	13
Risperidone	Risperidone	58	13
Triamcinolone Acetonide	Triamcinolone Acetonide	58	18
Citalopram Hbr	Citalopram Hydrobromide	56	16
Gemtesa	Vibegron	56	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	54	11
Meloxicam	Meloxicam	54	11
Bisoprolol Fumarate	Bisoprolol Fumarate	51	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	51	11
Divalproex Sodium	Divalproex Sodium	49	suppressed
Ezetimibe	Ezetimibe	49	suppressed
Olanzapine	Olanzapine	49	suppressed
Jardiance	Empagliflozin	47	suppressed
Nystatin	Nystatin	47	29
Oxycodone Hcl	Oxycodone Hcl	47	22
Alendronate Sodium	Alendronate Sodium	46	suppressed
Ondansetron Hcl	Ondansetron Hcl	45	34
Fluoxetine Hcl	Fluoxetine Hcl	42	13
Xarelto	Rivaroxaban	42	suppressed
Montelukast Sodium	Montelukast Sodium	41	suppressed
Prednisone	Prednisone	41	12
Ropinirole Hcl	Ropinirole Hcl	41	suppressed
Glimepiride	Glimepiride	39	suppressed
Paroxetine Hcl	Paroxetine Hcl	38	suppressed
Diclofenac Sodium	Diclofenac Sodium	37	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	37	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	37	suppressed
Metformin Hcl Er	Metformin Hcl	35	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	35	suppressed
Hydralazine Hcl	Hydralazine Hcl	34	suppressed
Carvedilol	Carvedilol	32	12
Oxybutynin Chloride Er	Oxybutynin Chloride	31	suppressed
Topiramate	Topiramate	31	suppressed
Torsemide	Torsemide	31	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	31	suppressed
Amiodarone Hcl	Amiodarone Hcl	30	suppressed
Bupropion Xl	Bupropion Hcl	30	suppressed
Cephalexin	Cephalexin	30	28
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	suppressed
Januvia	Sitagliptin Phosphate	30	suppressed
Levetiracetam	Levetiracetam	29	suppressed
Trulicity	Dulaglutide	29	suppressed
Glipizide	Glipizide	28	suppressed
Lamotrigine	Lamotrigine	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Midodrine Hcl	Midodrine Hcl	28	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	28	suppressed
Aripiprazole	Aripiprazole	27	suppressed
Divalproex Sodium Er	Divalproex Sodium	27	suppressed
Ibuprofen	Ibuprofen	27	suppressed
Multaq	Dronedarone Hcl	27	suppressed
Solifenacin Succinate	Solifenacin Succinate	26	suppressed
Baclofen	Baclofen	25	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	16
Invega Sustenna	Paliperidone Palmitate	24	suppressed
Valsartan	Valsartan	24	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	24	suppressed
Benztropine Mesylate	Benztropine Mesylate	23	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	22	14
Fanapt	Iloperidone	22	suppressed
Mycophenolate Mofetil	Mycophenolate Mofetil	22	suppressed
Admelog Solostar	Insulin Lispro	21	suppressed
Arnuity Ellipta	Fluticasone Furoate	21	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Amantadine	Amantadine Hcl	20	suppressed
Finasteride	Finasteride	20	suppressed
Glipizide Er	Glipizide	20	suppressed
Vilazodone Hcl	Vilazodone Hcl	20	suppressed
Clonazepam	Clonazepam	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Arformoterol Tartrate	Arformoterol Tartrate	18	suppressed
Austedo	Deutetrabenazine	17	suppressed
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	17	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Pravastatin Sodium	Pravastatin Sodium	17	suppressed
Buprenorphine	Buprenorphine	16	suppressed
Carbamazepine	Carbamazepine	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Felodipine Er	Felodipine	16	suppressed
Single Use Swab	Alcohol Antiseptic Pads	16	suppressed
Timolol Maleate	Timolol Maleate	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Nebivolol Hcl	Nebivolol Hcl	15	suppressed
Ranolazine Er	Ranolazine	15	suppressed
Restasis	Cyclosporine	15	suppressed
Vascepa	Icosapent Ethyl	15	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Tresiba Flextouch U-200	Insulin Degludec	14	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	14	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Levofloxacin	Levofloxacin	13	12
Liothyronine Sodium	Liothyronine Sodium	13	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	13	suppressed
Niacin Er	Niacin	13	suppressed
Fentanyl	Fentanyl	12	suppressed
Glycopyrrolate	Glycopyrrolate	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Methimazole	Methimazole	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	11	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Ingrezza	Valbenazine Tosylate	11	suppressed
Jentadueto	Linagliptin/Metformin Hcl	11	suppressed
Methenamine Hippurate	Methenamine Hippurate	11	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	11	suppressed
Scopolamine	Scopolamine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error